United States · FDA National Drug Code directory
ATORVASTATIN CALCIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1051_7dd59be7-0b85-434a-925b-e2b9926f9e45
- Product NDC
- 71335-1051
- Form
- TABLET, FILM COATED
- Composition / generic term
- ATORVASTATIN CALCIUM
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120529
- Source listing expiry
- 20261231
Source-listed ingredients
- ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (71335-1051-1) · 71335-1051-1
- 60 TABLET, FILM COATED in 1 BOTTLE (71335-1051-2) · 71335-1051-2
- 90 TABLET, FILM COATED in 1 BOTTLE (71335-1051-3) · 71335-1051-3
- 9 TABLET, FILM COATED in 1 BOTTLE (71335-1051-4) · 71335-1051-4
- 28 TABLET, FILM COATED in 1 BOTTLE (71335-1051-5) · 71335-1051-5
- 20 TABLET, FILM COATED in 1 BOTTLE (71335-1051-6) · 71335-1051-6
- 180 TABLET, FILM COATED in 1 BOTTLE (71335-1051-7) · 71335-1051-7
- 100 TABLET, FILM COATED in 1 BOTTLE (71335-1051-8) · 71335-1051-8
- 7 TABLET, FILM COATED in 1 BOTTLE (71335-1051-9) · 71335-1051-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →